Soci 2010 Soci 2011 Soci 2012 Soci 2013
« Indietro
26.09.2011

HELSINN GROUP

HELSINN GROUP AND EISAI INC. ANNOUNCE START OF PHASE III CLINICAL PROGRAM OF ORAL FIXED-DOSE COMBINATION OF NETUPITANT/ PALONOSETRON (300 mg/0.50 mg) FOR PREVENTION OF CHEMOTHERAPYINDUCED NAUSEA AND VOMITING (CINV)


Comunicato stampa Helsinn 1.pdf
 
 
Su

Username o email:

Password:

cancella testo (antispam)


Ricordami

Password dimenticata?

tiffany and co outlet oakley sunglasses christian louboutin Monster Beats By Dre Beats By Dre Studio Beats By Dre Solo Beats By Dre Tour Beats By Dre Wireless Fake Beats By Dre Tiffany Co Infinity Ring www.jewelrystores2013.com www.oakleyoutletsale2013.com